The Legal Intelligencer | News
By Max Mitchell | February 22, 2019
McKesson, which is facing claims that it misrepresented the vaccine's safety, filed a motion to dismiss Thursday in the U.S. District Court for the Eastern District of Pennsylvania, contending that 92 cases should be dismissed because the complaints failed to give sufficient details about the allegations.
By Charles Toutant | February 21, 2019
The suits were granted mass tort status after an investigation by the Food and Drug Administration found the drug contained trace amounts of a probable human carcinogen.
Corporate Counsel | Commentary
By Michael J. Harrington | February 21, 2019
Many of the law suits prominent in today's headlines—the ones concerning opioids, talc, NFL concussions and many pharmaceutical products—are part of a 50-year-old experiment in legal procedure known as multidistrict litigation whose vital signs are now flashing an immediate need for intensive care.
The Legal Intelligencer | News
By Max Mitchell | February 19, 2019
The defendants, which consist of 25 pharmaceutical companies, had argued that plaintiffs did not have standing to bring claims based on state laws in jurisdictions where the class representatives did not either purchase or resell the drugs at issue.
By Charles Toutant | February 15, 2019
The "Skuse" appeals court said the manner of presenting the arbitration clause was too "oblique" and failed to provide the requisite assent of employees.
By Tom McParland | February 8, 2019
A federal jury has ordered a unit of Takeda Pharmaceutical Co. to pay Bayer HealthCare LLC $155 million in damages for infringing a patent related to Bayer's hemophilia treatment.
By Amanda Bronstad | February 6, 2019
U.S. District Judge Dan Polster heard testimony Wednesday from Baker Hostetler partner Carole Rendon about her former job as U.S. Attorney for the Northern District of Ohio, during which she headed an opioid task force.
By Charles Toutant | January 16, 2019
The court said companies seeking to institute a mandatory arbitration policy for job-related disputes still must obtain their employees' knowing and explicit assent, even where the policy is disseminated electronically, rather than on paper.
By Michael Booth | December 19, 2018
The dispute involves a Merck shareholder and his opposition to Merck's $8.4 billion acquisition of Cubist Pharmaceuticals.
New Jersey Law Journal | Analysis
By Michael H. Reed | December 5, 2018
Does the U.S. Supreme Court's decision in 'Bristol Myers Squibb' apply to class actions?
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Blume Forte Fried Zerres and Molinari 1 Main Street Chatham, NJ 07945Prominent Morris County Law Firm with a state-wide personal injury prac...
d Arcambal Ousley & Cuyler Burk, LLP, a well-established women-owned litigation firm, has an opening in our Parsippany, NJ office. We of...
Our client, a litigation services boutique, is seeking to add a senior litigation associate to support their rapidly growing practice. A Big...